Want to see SSNC full AI Analyst Report?
SSNC Stock Chart & Stats
$83.47
$1.16(1.57%)
At close: 4:00 PM EDT
$83.47
$1.16(1.57%)
Day’s Range― - ―
52-Week Range$61.40 - $89.93
Previous Close$75.04
Volume2.19M
Average Volume (3M)1.36M
Market Cap
$19.73B
Enterprise Value$19.45B
Total Cash (Recent Filing)$434.80M
Total Debt (Recent Filing)$7.78B
Price to Earnings (P/E)23.5
Beta0.78
Next Earnings
Oct 22, 2026EPS Estimate
1.77Next Dividend Ex-DateN/A
Dividend Yield1.32%
Share Statistics
EPS (TTM)3.58
Shares Outstanding234,655,000
10 Day Avg. Volume1,195,378
30 Day Avg. Volume1,360,211
Financial Highlights & Ratios
PEG Ratio4.87
Price to Book (P/B)3.10
Price to Sales (P/S)3.40
P/FCF Ratio12.83
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue2.96
Enterprise Value/Gross Profit6.16
Enterprise Value/Ebitda8.74
Forecast
1Y Price Target
$91.43Price Target Upside9.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)7.11
Revenue Forecast (FY)$6.76B
Bulls Say, Bears Say
Bulls Say
Recurring, Mission-critical RevenueRecurring revenue from mission-critical financial and healthcare workflows can support renewals and stable cash generation over time. High switching costs, multi-year contracts, and opportunities to add modules or outsourced services provide a durable foundation for client retention and account expansion.
Strong Cash GenerationStrong operating and free cash flow, closely aligned with net income, supports earnings quality and gives SS&C meaningful capacity to invest, return capital, and manage obligations. The multi-year improvement indicates cash generation is an established business strength rather than a single-period result.
Raised Growth And Margin OutlookRaised full-year guidance indicates management expects continued demand and operating leverage beyond the latest quarter. The combination of organic growth, EBITDA expansion, and higher expected cash from operations supports improving earnings power and reinforces confidence in execution over the next several quarters.
Bears Say
Meaningful Leverage And Refinancing ExposureA substantial debt load and 2.75x net leverage can constrain financial flexibility if operating performance weakens. Prioritizing buybacks over debt reduction leaves less immediate deleveraging, while planned refinancing of 2027 maturities exposes future cash costs to financing conditions.
Material GAAP And Adjusted Earnings GapThe wide difference between GAAP and adjusted earnings makes underlying profitability harder to assess and reduces the transparency of reported performance. Persistent adjustments can weaken earnings quality, complicate comparisons across periods, and increase reliance on management-defined measures for evaluating progress.
Investment And Expense PressureRising core expenses alongside substantial investment in AI, software, and acquisitions may limit near-term margin conversion even when revenue grows. These spending requirements also increase execution demands, making sustained operating leverage dependent on successfully realizing benefits from new initiatives.
SS&C Technologies Holdings News
SSNC FAQ
What was SS&C Technologies Holdings’s price range in the past 12 months?
SS&C Technologies Holdings lowest stock price was $61.40 and its highest was $89.93 in the past 12 months.
What is SS&C Technologies Holdings’s market cap?
SS&C Technologies Holdings’s market cap is $19.73B.
When is SS&C Technologies Holdings’s upcoming earnings report date?
SS&C Technologies Holdings’s upcoming earnings report date is Oct 22, 2026 which is in 3 days.
How were SS&C Technologies Holdings’s earnings last quarter?
SS&C Technologies Holdings released its earnings results on Jul 23, 2026. The company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.679 by $0.081.
Is SS&C Technologies Holdings overvalued?
According to Wall Street analysts SS&C Technologies Holdings’s price is currently Undervalued.
Does SS&C Technologies Holdings pay dividends?
SS&C Technologies Holdings pays a Quarterly dividend of $0.3 which represents an annual dividend yield of 1.32%. See more information on SS&C Technologies Holdings dividends here
What is SS&C Technologies Holdings’s EPS estimate?
SS&C Technologies Holdings’s EPS estimate is 1.77.
How many shares outstanding does SS&C Technologies Holdings have?
SS&C Technologies Holdings has 234,655,000 shares outstanding.
What happened to SS&C Technologies Holdings’s price movement after its last earnings report?
SS&C Technologies Holdings reported an EPS of $1.76 in its last earnings report, beating expectations of $1.679. Following the earnings report the stock price went up 10.351%.
Which hedge fund is a major shareholder of SS&C Technologies Holdings?
Currently, no hedge funds are holding shares in SSNC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SS&C Technologies Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$91.43 (9.53% Upside)
$91.43 (9.53% Upside)
Blogger Sentiment
Bullish
SSNC Sentiment 63%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Increased
By 180.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.22%
12-Months-Change
Fundamentals
Return on Equity
12.66%
Trailing 12-Months
Asset Growth
8.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
SS&C Technologies Holdings
SS&C Technologies Holdings, Inc. offers a diverse portfolio of software solutions and related services, catering primarily to the financial services and healthcare industries. The company's sophisticated technology infrastructure spans various critical functions within finance, including securities accounting; front-office capabilities such as trading and financial modeling; middle-office tasks like portfolio oversight and reporting; and comprehensive back-office operations encompassing general accounting, performance measurement, data reconciliation, processing, clearing, regulatory compliance, and tax reporting. In the healthcare sector, SS&C provides specialized solutions for claims adjudication, benefits administration, care management, and business intelligence. These offerings are instrumental in helping professionals in both domains automate intricate business processes and efficiently handle their extensive information processing demands. SS&C's wide array of software-enabled services includes prominent platforms like SS&C GlobeOp, Global Investor and Distribution Solutions, SS&C Retirement Solutions, Black Diamond Wealth Platform, Bluedoor, Advent Outsourcing Services, Advent Data Solutions, ALPS Advisors, and Virtual Data Rooms, alongside specific services for pharmacy, healthcare administration, and health outcomes optimization. Its core software products feature tools for portfolio and investment accounting and analytics, holistic portfolio management, trading, digital process automation, and banking and lending, complemented by research, risk analysis, and training applications. Additionally, the company extends professional services, offering expert consulting and implementation support, along with dedicated product assistance. Operating on a global scale, SS&C maintains a significant footprint across the United States, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific region including Japan, Canada, and the broader Americas. Established in 1986, the company is based in Windsor, Connecticut.
SSNC Company Deck
SSNC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum and record adjusted financial results (revenue, EBITDA, EPS) alongside substantial shareholder returns and promising commercial traction (AI, tokenization, DomaniRx). These positives are moderated by a high leverage profile, quarter-to-quarter lumpiness driven by renewal timing, notable GAAP/non-GAAP differences, and ongoing investment needs. Management raised full-year guidance while balancing buybacks and potential refinancing plans, signaling confidence but with capital structure and program continuity risks to monitor.View all SSNC earnings summariesSSNC Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$91.43
▲(9.53% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
14.27% Insiders
22.96% Mutual Funds
1.81% Other Institutional Investors
45.51% Public Companies and
Individual Investors












